153 related articles for article (PubMed ID: 24906843)
1. Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation.
Münscher A; Sehner S; Taleh J; Tribius S; Möckelmann N; Böttcher A; Gulati A; Dalchow C; Clauditz T; Knecht R
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1769-75. PubMed ID: 24906843
[TBL] [Abstract][Full Text] [Related]
2. Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.
Sokoya M; Chowdhury F; Kadakia S; Ducic Y
Laryngoscope; 2018 Nov; 128(11):2573-2575. PubMed ID: 30194842
[TBL] [Abstract][Full Text] [Related]
3. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
4. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
5. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY
J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
7. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
8. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.
McDermott M; Hughes M; Rath T; Johnson JT; Heron DE; Kubicek GJ; Kim SW; Ferris RL; Duvvuri U; Ohr JP; Branstetter BF
AJNR Am J Neuroradiol; 2013 Aug; 34(8):1632-6. PubMed ID: 23639557
[TBL] [Abstract][Full Text] [Related]
9. Observing stage-shifts in head and neck squamous cell carcinoma from initial clinical outpatient staging to definite clinical tumour board staging using radiological and endoscopical investigations: will less do?
Braunius WW; van Gils CH; Rosenberg AJ; Hordijk GJ; Moons KG
Clin Otolaryngol; 2011 Aug; 36(4):352-60. PubMed ID: 21635696
[TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
[TBL] [Abstract][Full Text] [Related]
11. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma.
Rodriguez-Bruno K; Ali MJ; Wang SJ
Head Neck; 2011 Jul; 33(7):949-53. PubMed ID: 21674670
[TBL] [Abstract][Full Text] [Related]
12. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
14. A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue.
Koo K; Harris R; Wiesenfeld D; Iseli TA
J Laryngol Otol; 2015 Jan; 129 Suppl 1():S27-31. PubMed ID: 25656280
[TBL] [Abstract][Full Text] [Related]
15. Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck.
Sullivan BP; Parks KA; Dean NR; Rosenthal EL; Carroll WR; Magnuson JS
Head Neck; 2011 Nov; 33(11):1547-50. PubMed ID: 21990217
[TBL] [Abstract][Full Text] [Related]
16. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
[TBL] [Abstract][Full Text] [Related]
17. Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.
Kolk A; Schuster T; Chlebowski A; Lange P; Scheidhauer K; Kesting M; Bissinger O; Schwaiger M; Dinges J; Weitz J
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1363-74. PubMed ID: 24573657
[TBL] [Abstract][Full Text] [Related]
18. Routine surveillance scanning in HNSCC: Lung screening CT scans have value but head and neck scans do not.
Iovoli AJ; Platek AJ; Degraaff L; Wang C; Duncan WD; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Platek ME; Singh AK
Oral Oncol; 2018 Nov; 86():273-277. PubMed ID: 30409312
[TBL] [Abstract][Full Text] [Related]
19. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
20. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
